MD Anderson Cancer Center Board of Visitors adds 16 new members
MD Anderson News Release October 19, 2012
Business, community leaders nationwide join efforts in Making Cancer History®
MD Anderson News Release 10/19/12
The MD Anderson Cancer Center Board of Visitors (BOV), an appointive board of volunteers dedicated to advancing the initiatives of The University of Texas
MD Anderson Cancer Center, welcomes 16 new associate members and a new slate of officers as of Sept. 1.
Officers leading this year’s efforts are:
• Chair ― Harry J. Longwell, Dallas
• Chair Elect ― Melvyn N. Klein, Corpus Christi
• Vice Chair ― James J. Mulva, Houston
• Immediate Past Chair ― Nancy B. Loeffler, San Antonio
New BOV members are:
• Mark Albers ― The Woodlands, Texas
• Cindy Citrone ― Southport, Conn.
• Lily Garfield ― Aspen, Colo.
• Marie Goradia, Ph.D. ― The Woodlands, Texas
• Katherine C. Hatcher ― Houston
• T. Mark Kelly ― Houston
• Pierre F. Lapeyre Jr. ― New York
• Karen R. Matthews ― Dallas
• Howard M. Meyers ― Dallas
• Denise Monteleone ― Houston
• William C. Montgomery ― Houston
• Joseph Neubauer ― Philadelphia, Penn.
• Melinda Hill Perrin ― Houston
• John Shields II ― Ponte Vedra Beach, Fla.
• Charles W. Stiefel ― Raleigh, N.C.
• Michel H. Williams ― Bloomfield, Mich.
“Each of these new members brings a wealth of talent and expertise to our initiatives. I’m proud to welcome them to the board, and I look forward to their collective support in helping MD Anderson make great strides toward Making Cancer History®,” said Longwell.
Since the board’s inception in 1957, BOV members have played a significant role in MD Anderson’s mission to eradicate cancer by helping raise funds, awareness and support for the institution.
“We’re grateful to these business and community leaders from across the nation for not only their efforts to secure philanthropic contributions to the institution, but also for their personal gifts of time, resources and talents,” said Ronald DePinho, M.D., president of MD Anderson. “Their generosity is crucial in advancing the institution’s cancer research and patient care initiatives. Certainly the BOV’s support will have a significant role in achieving our goals to drastically reduce cancer mortality through the recently announced Moon Shots Program.”